Seeking Alpha

Tekmira +4% on takeover rumors; Shire, Glaxo said to have interest

  • Tekmira Pharma (NASDAQ:TKMR) +4.2% AH following a Daily Mail story suggesting it is a takeover candidate, after shares have nearly doubled in the past month thanks to attention over its experimental treatment for the deadly ebola virus.
  • Rumors suggest interested parties could include Shire (NASDAQ:SHPG) and GlaxoSmithKline (NYSE:GSK); the report suggests the recent premium paid for  InterMune could put a valuation of at least $40/share on TKMR.
From other sites
Comments (10)
  • john812
    , contributor
    Comments (42) | Send Message
    I will take that.
    27 Aug 2014, 07:05 PM Reply Like
  • cautionsvestor
    , contributor
    Comments (29) | Send Message
    The daily mail said the same thing about $ARIA couple of months ago :)
    27 Aug 2014, 07:12 PM Reply Like
  • BioDoubt
    , contributor
    Comments (19) | Send Message
    And countless others as well. They are always wrong, but yet retail traders bid it up every single time.
    27 Aug 2014, 07:48 PM Reply Like
  • flyerguy1300
    , contributor
    Comments (658) | Send Message
    I'll take the takeover more profit for me :)
    27 Aug 2014, 07:41 PM Reply Like
  • Amerc96
    , contributor
    Comments (9) | Send Message
    Statistically, shorting into the teeth of these kind of rumors has been a winning play......just sayin....
    27 Aug 2014, 07:42 PM Reply Like
  • shakazoid
    , contributor
    Comments (247) | Send Message
    A new sucker is born everyday for Daily mail. It is the Fox news of M&A
    27 Aug 2014, 07:56 PM Reply Like
  • temac
    , contributor
    Comment (1) | Send Message
    Temack50, I truly enjoyed the write up i'm long tkmr and believe in their progress. I currently work in molecular, anti-body and peptide imaging for diagnostic and therapeutic treatments i hope they succeed.
    27 Aug 2014, 09:05 PM Reply Like
  • patfactorx
    , contributor
    Comments (115) | Send Message
    Fast money is fast money
    28 Aug 2014, 01:03 AM Reply Like
  • great article
    , contributor
    Comments (3) | Send Message
    As long as ebola continues to claim lives, TKMR will continue to surge. It's likely to see $32 short term before it's said and done, and unless there is a buyout as rumored.
    30 Aug 2014, 08:57 AM Reply Like
  • Amerc96
    , contributor
    Comments (9) | Send Message
    Good call.....hahahah
    7 Aug, 07:52 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs